Verification of A New Filter for Isolation of Circulating Tumor Cells by Only Blood Filtration.


Journal

Anticancer research
ISSN: 1791-7530
Titre abrégé: Anticancer Res
Pays: Greece
ID NLM: 8102988

Informations de publication

Date de publication:
Sep 2022
Historique:
received: 09 07 2022
revised: 19 07 2022
accepted: 20 07 2022
entrez: 30 8 2022
pubmed: 31 8 2022
medline: 1 9 2022
Statut: ppublish

Résumé

Since circulating tumor cells (CTCs) are precursors of metastatic lesions, extracting CTCs from whole blood is useful in obtaining information for cancer treatment. One of the CTC isolation methods is the size selection method; however, since the conventional methods are expensive and cumbersome, we developed an affordable and simple filter, whose usefulness is verified in this study. The new filter [hereafter, soft micropore filter (S-MPF)] is made up of a polyethylene film with a thickness of 15 μm and conical pores having a diameter of 8-10 μm, which are opened uniformly (opening rate, 20%). This filter can filter whole blood by free-falling under gravity. The possibilities of the filter's usage for model CTC isolation, immunostaining, short-term cell culture, and gene mutation detection in extracted model CTCs were verified. S-MPF was able to extract model CTCs with an isolation rate of up to 15%. These model CTCs were detected by cytology, immunostaining, and culture by short-term incubation of filtered cells. Furthermore, genetic mutations were identified in the cultured cells. In addition, CTC isolation from the peripheral blood of patients with lung cancer was demonstrated by setting the volume of collected blood to 15 ml to prevent a low recovery rate. The S-MPF can be used to extract model CTCs quickly and easily. Moreover, cytological diagnosis, immunostaining, short-term culture, and gene mutation search are possible with this filter. Given its proven applicability in clinical samples, this filter can be used in clinical settings.

Sections du résumé

BACKGROUND/AIM OBJECTIVE
Since circulating tumor cells (CTCs) are precursors of metastatic lesions, extracting CTCs from whole blood is useful in obtaining information for cancer treatment. One of the CTC isolation methods is the size selection method; however, since the conventional methods are expensive and cumbersome, we developed an affordable and simple filter, whose usefulness is verified in this study.
MATERIALS AND METHODS METHODS
The new filter [hereafter, soft micropore filter (S-MPF)] is made up of a polyethylene film with a thickness of 15 μm and conical pores having a diameter of 8-10 μm, which are opened uniformly (opening rate, 20%). This filter can filter whole blood by free-falling under gravity. The possibilities of the filter's usage for model CTC isolation, immunostaining, short-term cell culture, and gene mutation detection in extracted model CTCs were verified.
RESULTS RESULTS
S-MPF was able to extract model CTCs with an isolation rate of up to 15%. These model CTCs were detected by cytology, immunostaining, and culture by short-term incubation of filtered cells. Furthermore, genetic mutations were identified in the cultured cells. In addition, CTC isolation from the peripheral blood of patients with lung cancer was demonstrated by setting the volume of collected blood to 15 ml to prevent a low recovery rate.
CONCLUSION CONCLUSIONS
The S-MPF can be used to extract model CTCs quickly and easily. Moreover, cytological diagnosis, immunostaining, short-term culture, and gene mutation search are possible with this filter. Given its proven applicability in clinical samples, this filter can be used in clinical settings.

Identifiants

pubmed: 36039435
pii: 42/9/4305
doi: 10.21873/anticanres.15930
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4305-4310

Informations de copyright

Copyright © 2022 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Auteurs

Kohei Morita (K)

Department of Diagnostic Pathology, Nara Medical University School of Medicine, Kashihara, Japan.
Department of Diagnostic Pathology, Nara Prefecture General Medical Center, Nara, Japan.

Noriyoshi Sawabata (N)

Department of Thoracic and Cardio-Vascular Surgery, Nara Medical University School of Medicine, Kashihara, Japan; nsawabata@hotmail.com.

Shigenobu Tatsumi (S)

Department of Pathology and Diagnosis, Nara Medical University Hospital, Kashihara, Japan.

Tomomi Fujii (T)

Department of Diagnostic Pathology, Nara Medical University School of Medicine, Kashihara, Japan.

Takashi Nishikawa (T)

Department of Pathology and Diagnosis, Nara Medical University Hospital, Kashihara, Japan.

Takeshi Kawaguchi (T)

Department of Thoracic and Cardio-Vascular Surgery, Nara Medical University School of Medicine, Kashihara, Japan.

Toru Arakane (T)

Toray Industries, Inc., Tokyo, Japan.

Yoshiaki Tominaga (Y)

Toray Industries, Inc., Tokyo, Japan.

Hirokazu Sakaguchi (H)

Toray Industries, Inc., Tokyo, Japan.

Taro Kobayashi (T)

Ikeda Scientific Co., Ltd., Tokyo, Japan.

Shigeto Hontsu (S)

Department of Respiratory Medicine, Nara Medical University School of Medicine, Kashihara, Japan.

Yoshifumi Yamamoto (Y)

Department of Respiratory Medicine, Nara Medical University School of Medicine, Kashihara, Japan.

Nobuhiro Fujioka (N)

Department of Respiratory Medicine, Nara Medical University School of Medicine, Kashihara, Japan.

Noriko Ouji-Sageshima (N)

Department of Immunology, Nara Medical University School of Medicine, Kashihara, Japan.

Toshihiro Ito (T)

Department of Immunology, Nara Medical University School of Medicine, Kashihara, Japan.

Chiho Ohbayashi (C)

Department of Diagnostic Pathology, Nara Medical University School of Medicine, Kashihara, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH